RESEARCH TRIANGLE PARK, N.C. and SAN FRANCISCO, May 22, 2024 (GLOBE NEWSWIRE) -- G1 Therapeutics, Inc. (GTHX) (Nasdaq: GTHX), a commercial-stage oncology company, and Deimos Biosciences, a portfolio ...
G1 Therapeutics and Pepper Bio Announce Global (Excluding Asia-Pac) License Agreement for Lerociclib
RESEARCH TRIANGLE PARK, N.C. and BOSTON, May 01, 2024 (GLOBE NEWSWIRE) -- G1 Therapeutics, Inc. (GTHX) (Nasdaq: GTHX), a commercial-stage oncology company, and Pepper Bio, the world’s first transomics ...
RESEARCH TRIANGLE PARK, N.C. and CAMBRIDGE, Mass., July 22, 2020 (GLOBE NEWSWIRE) -- G1 Therapeutics, Inc. (Nasdaq: GTHX), a clinical-stage oncology company, today announced a license agreement for ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback